Antimalarials in systemic lupus erythematosus: benefits beyond disease activity

Author： Andrade Rosa M   Alarcón Graciela S  

Publisher： Future Medicine

ISSN： 1746-0816

Source： Future Rheumatology, Vol.1, Iss.2, 2006-04, pp. : 225-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease activity and antinucleosome antibodies in systemic lupus erythematosus

By Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio   Benucci Maurizio  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 1, 2003-01 ,pp. : 42-45

Informa Healthcare

Access to resources Recommend Favorite

NK cells dysfunction in systemic lupus erythematosus: relation to disease activity

By Henriques Ana  

Clinical Rheumatology, Vol. 32, Iss. 6, 2013-06 ,pp. : 805-813

Springer Publishing Company

Access to resources Recommend Favorite

Elevated interleukin-18 levels correlated with disease activity in systemic lupus erythematosus

By Park Min Chan   Park Yong Beom   Lee Soo Kon  

Clinical Rheumatology, Vol. 23, Iss. 3, 2004-06 ,pp. : 225-229

Springer Publishing Company

Access to resources Recommend Favorite

Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity

By Mader Reuven   Mishail Samer   Adawi Muhammed   Lavi Idit   Luboshitzky Rafael  

Clinical Rheumatology, Vol. 26, Iss. 11, 2007-11 ,pp. : 1891-1894

Springer Publishing Company

Access to resources Recommend Favorite

BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus

By Zhu Li-Wei   Zhang Tao   Pan Hai-Feng   Li Xiang-Pei   Ye Dong-Qing  

Clinical Rheumatology, Vol. 29, Iss. 12, 2010-12 ,pp. : 1413-1417

Springer Publishing Company

Access to resources Recommend Favorite